Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsGold Coast Health Plan Botulinum Coverage | OpenPa…
    Ask Trek AI about this page
    CurrentGold Coast Health PlanPolicy N/A

    Botulinum Toxins

    Customize your policy alerts

    Sign up for all goldcoasthealthplan policy alerts

    Know when goldcoasthealthplan releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs coverage of medically necessary Botulinum Toxins A and B under Gold Coast Health Plan Total Care Advantage Medicare coverage for eligible beneficiaries. It provides guidance on medical necessity and indications, with detailed indications directed to the Provider Resources Medicare Part B Drugs resource.

    Policy Summary
    PayerGold Coast Health Plan
    PolicyBotulinum Toxins
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateSep 3, 2026
    Last ReviewSep 3, 2026
    Next Review DateN/A
    Key ActionRefer to Provider Resources > Medicare Part B Drugs for applicable indications.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    2Botulinum toxin types covered when medically necessary
    All eligible beneficiariesBeneficiary population identified for the covered benefit
    Medicare Part B DrugsResource containing detailed indications

    Medically Necessary Botulinum Toxin Therapy

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Medically necessary botulinum toxin therapy

    Covered when medically necessary for an eligible beneficiary.

    Coverage requirements

    • Drug type: Botulinum Toxin A or Botulinum Toxin B
    • Medical necessity: The botulinum toxin treatment is medically necessary.
    • Eligibility: The individual is an eligible beneficiary under Total Care Advantage.

    Policy Background

    Botulinum Toxins A and B are covered benefits under Gold Coast Health Plan Total Care Advantage for all eligible Medicare beneficiaries when medically necessary. Providers should refer to Provider Resources > Medicare Part B Drugs for the applicable indications.

    Policy Summary
    PayerGold Coast Health Plan
    PolicyBotulinum Toxins
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateSep 3, 2026
    Last ReviewSep 3, 2026
    Next Review DateN/A
    Key ActionRefer to Provider Resources > Medicare Part B Drugs for applicable indications.
    SourceLink
    On This Page
    Medically Necessary Botulinum Toxin TherapyPolicy Background